Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|August 12, 2021
The Roles of Kidney-Resident ILC2 in Renal Inflammation and FibrosisRyuichi Nagashima, Masayuki IyodaAmerican Journal of Physiology. Cell Physiology|July 24, 2025
The IL-33/ST2/ILC2 pathway in kidney disease: balancing inflammation, fibrosis, and repairYasunari Matsuzaka, Masayuki IyodaFrontiers in Radiology|January 26, 2026
Applications, image analysis, and interpretation of computer vision in medical imagingYasunari Matsuzaka, Masayuki IyodaPathology International|March 31, 2015
A case of sporadic medullary cystic kidney disease type 1 (MCKD1) with kidney enlargement complicated by IgA nephropathyTaihei Suzuki, Masayuki Iyoda, Yutaka Yamaguchi, et al.Kidney International|June 16, 2005
Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathyAki Kuroki, Masayuki Iyoda, Takanori Shibata, et al.Current Issues in Molecular Biology|July 23, 2025
Construction and Evaluation of a HCoV-OC43 S2 Subunit Vaccine Fused with Nasal Immuno-Inducible Sequence Against Coronavirus InfectionHiraku Sasaki, Hiroki Ishikawa, Ayako Shigenaga, et al.Cytokine|July 22, 2022
IL-33 attenuates renal fibrosis via group2 innate lymphoid cellsRyuichi Nagashima, Hiroki Ishikawa, Yoshihiro Kuno, et al.Scientific Reports|February 1, 2023
HIF-PHD inhibitor regulates the function of group2 innate lymphoid cells and polarization of M2 macrophagesRyuichi Nagashima, Hiroki Ishikawa, Yoshihiro Kuno, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|June 18, 2023
Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Podocytes in Mouse Nephrotic SyndromeTaihei Suzuki, Masayuki Iyoda, Nobuhiro Kanazawa, et al.British Journal of Pharmacology|December 8, 2010
Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty ratsYoshihiro Kuno, Masayuki Iyoda, Takanori Shibata, et al.Pageof 7